Results 41 to 50 of about 21,123 (250)
Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy [PDF]
SA Kingsberg¹, S Kellogg², M Krychman³1University Hospitals Case Medical Center, Case Western Reserve University Cleveland OH, USA; 2The Pelvic and Sexual Health Institute of Philadelphia, Drexel University College of Medicine,
SA Kingsberg, M Krychman, S Kellogg
core
Investigation of the relationships among self-efficacy, stress, and dyspareunia during the COVID-19 Pandemic [PDF]
This study examined whether low self-efficacy and heightened perceived stress were associated with dyspareunia at two timepoints during COVID-19. Sixty-two participants (31 with and 31 without dyspareunia) completed a longitudinal online survey.
Jackowich, Robyn A. +4 more
core +1 more source
The effect of isoflavone on vaginal dryness and dyspareunia in postmenopausal symptoms: a systematic review and meta-analysis [PDF]
Vaginal dryness and dyspareunia are frequent complaints among postmenopausal women. Studies have shown that isoflavones reduce the severity of menopausal symptoms. This study aimed to evaluate the effects of isoflavones on vaginal dryness and dyspareunia
Tri Hastono Setyo Hadi +3 more
doaj +1 more source
Objective: To evaluate the safety and efficacy rate of polyvinylidene fluoride (PVDF) slings in the treatment of female stress urinary incontinence (SUI).
Bara Barakat +2 more
doaj +1 more source
Pelvic venous disorders in women: Diagnosis and management for gynecologists
Abstract Pelvic venous disorders (PeVD) are an underrecognized yet significant cause of chronic pelvic pain (CPP) in reproductive‐aged women, characterized by venous reflux, obstruction, or both. This clinical opinion provides a practical overview of PeVD for gynecologists, outlining its pathophysiology, common presentations, diagnostic approach, and ...
Tiffany Ni +5 more
wiley +1 more source
Introduction: Sexual dysfunction is a complaint that could happened because of disturbance in complex process which coordinated by neurology system, vascular and endocrine system.1 One cause of sexual disfunction is dyspareunia which also followed by ...
Edy Fakhrizal, M. Lingga Primananda
doaj +1 more source
Abstract Objective To compare pain, menstrual flow, and quality of life (QoL) between women undergoing surgery for endometriosis only compared with women with endometriosis and coexisting adenomyosis. Methods A cross‐sectional study, set in two tertiary hospitals, of reproductive‐aged women (18–50 years) with a preoperative imaging diagnosis of ...
Mariana Matzenbacher Brunoro +5 more
wiley +1 more source
Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and breast [PDF]
Lin H Soe, Gregory T Wurz, Chiao-Jung Kao, Michael W DeGregorio Department of Internal Medicine, Division of Hematology and Oncology, School of Medicine, University of California, Davis, Sacramento, CA, USA Abstract: Ospemifene is a selective estrogen ...
Wurz GT, DeGregorio MW, Kao CJ, Soe LH
core
Interrelationships among endometriosis-related pain symptoms and their effects on health-related quality of life: a sectional observational study [PDF]
ObjectiveTo assess the correlation between different pain symptoms and different domains of women's health-related quality of life (HRQoL).MethodsSeventy-seven women with deep infiltrating endometriosis were successively enrolled between June 2011 and ...
Marlon de Freitas Fonseca +4 more
doaj +1 more source
Abstract Objective The aim of the present study was to determine whether advanced maternal age is associated with increased risk of perineal injury and obstetric anal sphincter injury (OASI) among primiparous women. Methods This was a retrospective cohort study of primiparous women aged 20–50 years with singleton term pregnancies in cephalic ...
Omri Dominsky +6 more
wiley +1 more source

